Home › Funds › Goldman Sachs › Goldman Sachs MSCI World Private Equity Return Tracker ETF
Fund family: Goldman Sachs · Filed by Goldman Sachs ETF Trust (CIK 1479026) · SEC series S000095713
Ticker: GTPE (C000264456)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 15,783 with, 170 against, 15 abstentions (not counted as with management); 132 items carried no recommendation; 9 split votes are in neither count. Shareholder proposals: 83 FOR, 149 AGAINST, 1 abstained, by the filing’s own vote-source field.
The same two figures as Goldman Sachs’s manager page (297,743 ballot items across 86 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Goldman Sachs | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 94.3% | 13,412 | 94.3% | 240,212 |
| Backed environmental and social shareholder proposals at US companies | n/a | 44 | 0.0% | 2,372 |
Each ballot item this fund voted is set against the votes of the other Goldman Sachs funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most Goldman Sachs funds on 2 items (0.1% of the 7,655 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most Goldman Sachs funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Arrow Electronics, Inc. | 2026-05-12 | Shareholder Shareholder proposal to provide shareholders with the ability to call a special shareholder meeting at a 10% ownership threshold. | Against | FOR — 5 of 7 Goldman Sachs funds | For | — |
| Concentrix Corporation | 2026-03-25 | Approval of an amendment to the Company's 2020 Stock Incentive Plan to increase the number of shares available for issuance. | For | AGAINST — 2 of 3 Goldman Sachs funds | For | Approved, 69.8% support |
Download all 2 differences (CSV)
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 7,844 | 3 |
| Corporate Governance | 2,434 | 95 |
| Compensation | 1,773 | 9 |
| Capital Structure | 1,725 | 1 |
| Audit-related | 1,373 | 1 |
| Say-on-Pay | 717 | 2 |
| Extraordinary Transactions | 83 | 0 |
| Other Social Issues | 81 | 21 |
| Other | 46 | 0 |
| Shareholder Rights and Defenses | 40 | 10 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Advanced Micro Devices, Inc. | May 13, 2026 | $1M | 12 | 1 |
| Palantir Technologies Inc. | June 3, 2026 | $621,351 | 12 | 3 |
| Eli Lilly and Company | May 4, 2026 | $590,623 | 10 | 2 |
| Marvell Technology, Inc. | June 25, 2026 | $563,997 | 10 | 1 |
| Vertex Pharmaceuticals Incorporated | May 13, 2026 | $522,194 | 14 | 1 |
| GE Vernova Inc. | May 20, 2026 | $454,181 | 6 | 1 |
| NVIDIA Corporation | June 24, 2026 | $420,017 | 16 | 4 |
| Broadcom Inc. | April 20, 2026 | $392,745 | 10 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 13, 2026 | Advanced Micro Devices, Inc. | Stockholder proposal requesting changes to the stockholder right to call a special meeting. Shareholder proposal | Against | For |
| June 3, 2026 | Palantir Technologies Inc. | Stockholder proposal entitled "Independent Report on Due Diligence Process," if properly presented at the Annual Meeting. Shareholder proposal | Against | For |
| June 3, 2026 | Palantir Technologies Inc. | Stockholder proposal entitled "Human Rights Impact Assessment," if properly presented at the Annual Meeting. Shareholder proposal | Against | For |
| May 4, 2026 | Eli Lilly and Company | Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposal | Against | For |
| May 4, 2026 | Eli Lilly and Company | Shareholder proposal to prepare an annual lobbying report. Shareholder proposal | Against | For |
| June 25, 2026 | Marvell Technology, Inc. | To consider and act on one stockholder proposal, entitled "Independent Board Chairman", if properly presented at the Annual Meeting. Shareholder proposal | Against | For |
| May 13, 2026 | Vertex Pharmaceuticals Incorporated | Shareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written consent. Shareholder proposal | Against | For |
| May 20, 2026 | GE Vernova Inc. | Stockholder proposal requesting report assessing sustainability goals on the basis of net-present-value and return-on-investment calculation Shareholder proposal | Against | For |
| June 24, 2026 | NVIDIA Corporation | Approval of a non-binding stockholder proposal requesting the replacement of supermajority voting provisions in our charter and bylaws with a simple majority voting standard. Shareholder proposal | For | Against |
| June 24, 2026 | NVIDIA Corporation | Approval of a non-binding stockholder proposal requesting a report on faith-based community resource groups. Shareholder proposal | Against | For |
| May 12, 2026 | Lockheed Martin Corporation | Stockholder Proposal Requiring Independent Board Chairman Shareholder proposal | Against | For |
| June 16, 2026 | Mastercard Incorporated | Consideration of a stockholder proposal regarding shareholder right to act by written consent Shareholder proposal | Against | For |
Meetings with a proxy contest or competing nominees (2 in 2025-2026), and how the fund voted the items on its ballot.
16,153 ballot items at 1,269 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Goldman Sachs MSCI World Private Equity Return Tracker ETF (GTPE) voted at 1,269 shareholder meetings of 1,232 companies, on 16,153 ballot items in all. Where management made a recommendation, the fund followed it on 98.8% of the items and voted against it 170 times. Its most frequent area of disagreement was corporate governance (95 of its votes against management). It voted FOR 35.8% of the 232 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals about as often as Goldman Sachs's funds as a whole (94.3% against 94.3%). It voted differently from most Goldman Sachs funds on 2 items. 2 of its meetings were contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Goldman Sachs’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.